Edition:
United Kingdom

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

672.10INR
10:29am GMT
Change (% chg)

Rs4.50 (+0.67%)
Prev Close
Rs667.60
Open
Rs668.00
Day's High
Rs679.80
Day's Low
Rs650.40
Volume
1,439,490
Avg. Vol
2,502,207
52-wk High
Rs809.45
52-wk Low
Rs503.05

Latest Key Developments (Source: Significant Developments)

Aurobindo Pharma gets U.S. FDA nod for esomeprazole magnesium DR capsules OTC
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Aurobindo Pharma Ltd :Says ‍received final approval from U.S. FDA to manufacture esomeprazole magnesium delayed-release capsules OTC, 20mg​.Says ‍product will be launched immediately​.  Full Article

Aurobindo Pharma gets USFDA approval for drugs used for treatement of HIV-1 infection
Monday, 21 Aug 2017 

Aug 21 (Reuters) - Aurobindo Pharma Ltd :Receives USFDA tentative approval for Dolutegravir, Lamivudine & Tenofovir Disoproxil Fumarate tablets.Drugs used for treatement of HIV-1 infection along as a regimen in adults and pediatric patients weighing over 40 kgs.  Full Article

Aurobindo Pharma gets USFDA tentative approval for Dolutegravir
Thursday, 22 Sep 2016 

Aurobindo Pharma Ltd :Aurobindo Pharma receives USFDA tentative approval for Dolutegravir, allowing the product to be launched in the PEPFAR market.  Full Article

Aurobindo Pharma receives USFDA approval for Linezolid injection
Monday, 8 Aug 2016 

Aurobindo Pharma Ltd : Aurobindo Pharma receives USFDA approval for Linezolid injection . Product is expected to be launched by Q2 FY 2016-17 .  Full Article

Aurobindo Pharma gets USFDA approval for rosuvastatin calcium tablets
Wednesday, 20 Jul 2016 

Aurobindo Pharma Ltd : Aurobindo Pharma receives usfda approval for rosuvastatin calcium tablets .  Full Article

Aurobindo Pharma gets USFDA approval for hydromorphone hydrochloride tablets
Tuesday, 17 May 2016 

Aurobindo Pharma Ltd : Aurobindo Pharma receives usfda approval for hydromorphone hydrochloride tablets .  Full Article

Aurobindo Pharma gets US FDA approval for bupivacaine hydrochloride injection
Monday, 16 May 2016 

Aurobindo Pharma Ltd : Gets US FDA approval for bupivacaine hydrochloride injection .  Full Article

Aurobindo Pharma gets USFDA approval for Zolmitriptan tablets
Friday, 13 May 2016 

Aurobindo Pharma Ltd : Receives USFDA approval for Zolmitriptan tablets; product expected to be launched in Q2 FY 2016-17 .  Full Article

Aurobindo Pharma gets USFDA approval for Fenofibrate tablets
Friday, 6 May 2016 

Aurobindo Pharma Ltd : Aurobindo Pharma receives USFDA approval for Fenofibrate tablets; product is expected to be launched in Q1 FY 2016-17 .  Full Article

Aurobindo Pharma Ltd receives USFDA Approval for Dexmedetomidine Hydrochloride Injection
Friday, 18 Mar 2016 

Aurobindo Pharma Ltd:Says that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Dexmedetomidine Hydrochloride Injection, 200 mcg (base)/2 mL (100 mcg (base)/mL) single-dose vials.  Full Article

BRIEF-Aurobindo Pharma Says News On Co Being Frontrunner to Buy Orchid Pharma "Factually Incorrect"

* AUROBINDO PHARMA CLARIFIES ON NEWS ITEM, "AUROBINDO, DR REDDY'S LABORATORIES FRONTRUNNERS TO BUY OUT BANKRUPT ORCHID PHARMA"